Dercle, L., Ammari, S., Roblin, E., Bigorgne, A., Champiat, S., Taihi, L., Plaian, A., Hans, S., Lakiss, S., Tselikas, L., Rouanne, M., Deutsch, E., Schwartz, L. H., Gönen, M., Flynn, J., Massard, C., Soria, J.-C., Robert, C., & Marabelle, A. (2022). High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy. European Journal of Cancer, 177, 80–93. https://doi.org/10.1016/j.ejca.2022.08.034